Benefits of Semelil (ANGIPARS™) on oxidant-antioxidant balance in diabetic patients; a randomized, double-blind placebo controlled clinical trial

Daru

Volumn 17, Issue SUPPL. 1, 2009, Pages 50-55

  Hemmatabadi, M ^a   Abdollahi, M ^b   Bakhshayeshi, S ^a   Heshmat, R ^a   Baeeri, M ^b   Azimaraghi, O ^b   Larijani, B ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angipars ; Diabetes mellitus; Oxidant antioxidant balance; Samelil

Indexed keywords

ANGIPARS; ANTIOXIDANT; C REACTIVE PROTEIN; CARBONYL DERIVATIVE; DEOXYGUANOSINE; GLUCOSE; HEMOGLOBIN; HEMOGLOBIN A1C; HERBACEOUS AGENT; HOMOCYSTEINE THIOLACTONE; INSULIN; MALONALDEHYDE; ORAL ANTIDIABETIC AGENT; PLACEBO; SEMELIL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC FOOT; DIABETIC PATIENT; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; KIDNEY FUNCTION TEST; LABORATORY TEST; LEUKOCYTE COUNT; LIPID PEROXIDATION; LIVER FUNCTION TEST; MALE; MELILOTUS OFFICINALIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDANT ANTIOXIDANT BALANCE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SERUM; SIDE EFFECT; THROMBOCYTE COUNT;

EID: 75449085698     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Robertson RP. Oxidative stress and impaired insulin secretion in type 2 diabetes. Curr Opin Pharmacol 2006; 6: 615-619.
2. Penckofer S, Schwertz D, Florczak K. Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and prooxidants. J Cardiovasc Nurs 2002; 16(2): 68-85.
3. Gopaul NK, Anggard EE, Mallet AI, Betteridge DJ, Wolff SP, et al. Plasma 8-epi-PGF2 alpha levels are elevated in individuals with NIDDM. FEBS Lett 1995; 368: 225-9.
4. Evans J.L, Goldfine I.D, Maddux B.A, Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002; 23 :599-622.
5. Lamb RE, Goldstein BJ. Modulating an oxidative inflammatory casade: potential new treatment strategy for improving glucose metabolism, insulin resistance and vascular function. Int J Clin Pract 2008; 62(7): 1087-1095.
6. Vessby J, Basu S, Mohsen R, Berne C,Vessby B. Oxidative stress and antioxidant status in type 1 diabetes mellitus. J Intern Med 2002; 251:69-76.
7. Dengel PS, Pratley RE, Hagberg JM, Rogus EM, Goldberg AP.Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men. J Appl Physiol 1996; 81: 318-325.
8. Larkins, Nicholas, Wynn S. Pharmacognosy: Phytomedicines and their mechanisms. Vet Clin North Am Small Anim Pract 2004; 34(1): 291-327.
9. Larijani B, Heshmat R, Bahrami A, Delshad H, Ranjbar Omrani G, Mohammad K, Heidarpour R,Mohajeri Tehrani MR, Kamali K, Farhadi M, Gharibdoust F, Madani SH. Effects of Intravenous Semelil (ANGIPARSTM) on Diabetic Foot Ulcers Healing: A Multicenter Clinical Trial. DARU 2008; 16: 35-40.
10. Sahin M, Tutuncu NB, Ertugrul D, Tanaci N, Guvener ND. Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and vitamin B12 in patients with type 2 diabetes mellitus. J Diabetes Complications 2007; 21: 118-23.
11. Benzi IF, Strain S. Ferric reducing antioxidant assay. Meth. Enzymol 1999; 292: 15-27.
12. Satho K. Serum lipid peroxidation in cerebrovascular disorders determined by a new colorimetric method. Clin Chem Acta 1978; 90: 37-43.
13. Levine RL, Garland D, Oliver CN, Amici A, et al. Determination of carbonyl content oxidatively modified proteins. Methods Enzymol 1990; 184: 464-478.
14. Breton J, Michael F. Measurement of 8-Hydroxy-2′-Deoxyguanosine by a commercially available ELISA Test: Comparison with HPLC/electrochemical detection in Calf thymus DNA and determination in human serum. Analytical Letters 2003; 36(1): 123-134.
15. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005: 59: 365-373.
16. Naziroglu M, Butterworth P. Protective effects of moderate exercise with dietary vitamin C and E on blood antioxidative defense mechanism in rats with streptozotocin-induced diabetes. Can J Appl Physiol 2005; 30(2): 172-85.
17. Klahr S, Morrissey JJ. The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int 2000; 57(Suppl 75): S7-S14.
18. Endo K, Miyashita Y, Sasaki H, et al. Probucol and atorvastatin decrease urinary 8 hydroxy 2 deoxy guanosin in patient with diabetes and hypercholesterolemia. J. Atheroschler.thromb 2006; 13: 68-75.
19. Shamimi Nouri K, Heshmat R, Karimian R, Nasli E, Larijani B, Novitsky YA, Farhadi M,Gharibdoust F. Intravenous ANGIPARS™ as a novel therapy for pressure Ulcer: A randomized clinical trial. DARU 2008; 16: 49-53.
20. Bahrami A, Kamali K, Ali-Asgharzadeh A, Hosseini P, Heshmat R, Khorram Khorram HR,Gharibdoust F, Madani SH, Larijani B. Clinical application of oral form of ANGIPARS™ and in combination with topical form as a new treatment for diabetic foot ulcers: A randomized clinical trial. DARU 2008; 16: 41-48.
21. Masoompour SM, Bagheri MH, Borhani Haghighi A, Novitsky YA, Sadeghi B, Gharibdoust F,Larijani B, Ranjbar Omrani G. Effect of ANGIPARS™, a new herbal drug on diabetic foot ulcer : A phase 2 clinical study. DARU 2008; 16: 31-34.
22. Heshmat R, Mohammad K, Mohajeri Tehrani MR, Tabatabaie Malazy O, Keshtkar AA, Gharibdoust F, Larijani B. Assessment of maximum tolerated dose of a new herbal drug, Semelil (ANGIPARSTM) in patients with diabetic foot ulcer: A Phase I clinical trial. DARU 2008; 16: 25-30.
23. Abdollahi M, Farzamfar B, Salari P, Khorrami Khorshid HR, Larijani B, Farhadi M, Madani SH. Evaluation of acute and sub-chronic toxicity of semelil (ANGIPARSTM), a new phyto therapeutic drug for wound healing in rodents. DARU 2008; 16(1): 7-14.
24. Farzamfar B, Minaie B, Mobtaker M, Salari P, Khorasani R, Abdollahi M. Effect of electromagnetic form of Melilotus Officinalis extract on dermal wound healing in diabetic Mice. Pharmacologyonline 2008: 2; 246 -254.
25. Kaneko T, Tahara S, Takabayashi F. Inhibitory effect of natural coumarin compounds, esculetin and esculin, on oxidative DNA damage and formation of aberrant crypt foci and tumors induced by 1,2- dimethylhydrazine in rat colons. Biol Pharm Bull 2007; 30(11): 2052-2057.
26. Ramesh B, Pugalendi KV. Antioxidant role of umbelliferon in STZ-diabetic rats. Life Sci 2006; 79: 306-310.
27. Dogra G, Rich L, Stanton K, Watts G. Endothelium-dependent and independent vasodilation studied at normoglycaemia in Type 1 diabetes mellitus with and without microalbuminuria. Diabetologia 2001; 44: 593-601.
28. Desco MC, Asensi M, Marquez R, et al. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 2002; 51(4): 1118-1124.
29. Afshari M, Larijani B, Rezaie A, Mojtahedi A, Zamani MJ, Astanehi-Asghari F, et al. Ineffectiveness of allopurinol in reduction of oxidative stress in diabetic patients; a randomized, double-blind placebo controlled clinical trial. Biomed Pharmacother 2004; 58(10): 546-550.
30. Radfar M, Larijani B, Hadjibabaie M, Rajabipour B, Mojtahedi A, Abdollahi M. Effects of pentoxifylline on oxidative stress and levels of EGF and NO in blood of diabetic type-2 patients:a randomized,double-blind placebo-controlled clinical trial. Biomed Pharmacother 2005; 59: 302-310.
31. Larijani B, Hasani-Ranjbar S. Overview of diabetic foot; novel treatments in diabetic foot ulcer DARU 2008; 16(Suppl. 1): 1-6. Gastroenterol 2009; 15: 1153-61.